HDN Treatment - Rhophylac

2024-06-12

Rhophylac is made from human source plasma collected from US donors using a patented manufacturing process called ChromaPlus. This unique manufacturing process not only helps minimize the risk of viral transmission, but also uses ion-exchange chromatography, a crucial element in delivering the purity to allow both intramuscular and intravenous administration by eliminating virtually all foreign aggregates from the source plasma.

Rhophylac is a sterile solution of anti-D, also known as Rho(D) Immune Globulin or Rh factor, which affords protection from Rh-sensitization or alloimmunization. Rhophylac® can be administered by intravenous (IV) or intramuscular (IM) injection.

HDN Treatment - Rhophylac